Outcomes of pericardial diseases in African-based populations
First author | Year of publication | Period of recruitment | Country | Study design | Data collection | Setting | Area | Disease-specific population | Treatment received | Sample size | Male % | Mean age | Age range | % of HIV | Diagnostic method | Duration of follow-up (in months) | Number of deceased | Mortality rate (%) |
Mayosi3 | 2008 | 2004 | Cameroon, Nigeria and South Africa | Cohort | Prospective | Hospital based | Urban | Presumed tuberculous pericarditis | Anti-TB treatment, steroids and pericardiocentesis. | 174 | 57 | 33 | 14–87 | 55.2 | Echocardiography, ECG, bacteriology and biochemistry. | 06 | 48 | 27.6 |
Mutyaba26 | 2014 | 1990–2012 | South Africa | Cohort | Retrospective | Hospital based | Urban | Constrictive pericarditis | Pericardiectomy. | 121 | 65.3 | 41.3 | 14–74 | 11.6 | Echocardiography, bacteriology and histology. | 01 | 17 | 14 |
Strang37 | 2004 | South Africa | RCT | Prospective | Hospital based | NR | tuberculous pericarditis | Anti-TB treatment, steroids, pericardiocentesis and pericardiostomy. | 383 | 43.8 | 49 | 5–78 | NR | Echocardiography. | 120 | 96 | 25 | |
Mynors24 | 1973 | 1967–1971 | Zimbabwe | Cross-sectional | Retrospective | Hospital based | NR | Pericarditis (86% tuberculous or acute purulent) | Depending on the aetiology: anti-TB treatment and pericardiectomy. | 57 | NR | NR | NR | NR | Radiology, surgery and postmortem. | NR | 15 | 26.3 |
Syed34 | 2013 | South Africa | Cohort | Prospective | Hospital based | Urban | Tuberculous pericarditis | 81 | 66.7 | 36.1 | 28–58 | 70.4 | Echocardiography, ECG and bacteriology. | 06 | 14 | 18 | ||
Pio13 | 2016 | 2011–2014 | Togo | Cross-sectional | Prospective | Hospital based | Urban | Pericardial effusions | Variable: anti-TB treatment, pericardiocentesis and pericardiostomy. | 38 | 42 | 42.5 | 16–73 | 47 | Echocardiography, ECG and bacteriology. | NR | 7 | 18 |
Maher36 | 1997 | 1993 | Malawi | Cohort | Prospective | Hospital based | Urban | Tuberculous pericarditis | Anti-TB treatment, steroids and pericardiocentesis. | 42 | NR | 29 | 18–54 | 84 | Echocardiography, chest X-ray, ECG and bacteriology. | 12 | 10 | 23.8 |
Reuter51 | 2005 | 1995–2001 | South Africa | Cross-sectional | Retrospective | Hospital based | Urban | Tuberculous pericardial effusion | Anti-TB treatment and pericardial surgery. | 162 | 56.7 | 38 | 13–85 | 36.1 | Echocardiography, bacteriology and cytology. | 12 | 28 | 17 |
Reuter51 | 2005 | 1995–2001 | South Africa | Cohort | Retrospective | Hospital based | Urban | Pericardial malignancy | Surgical drainage. | 22 | 56.7 | 38 | 13–85 | NR | Echocardiography, bacteriology and cytology. | 12 | 20 | 90 |
Reuter51 | 2005 | 1995–2001 | South Africa | Cohort | Retrospective | Hospital based | Urban | Large pericardial effusions | Depending on aetiology: anti-TB treatment and pericardial surgery. | 233 | 56.7 | 38 | 13–85 | Echocardiography, bacteriology and cytology. | 12 | 70 | 30 | |
Sidibe16 | 2007 | 2005–2006 | Mali | Cross-sectional | Retrospective | Hospital based | Urban | Pericardial disease in HIV patients | NR | 49 | 63.3 | 40.5 | NR | 100 | Echocardiography, chest X-ray, ECG and bacteriology. | NR | 18 | 36.7 |
Yangni-Angate38 | 2016 | 1977–2012 | Ivory Coast | Cross-sectional | Retrospective | Hospital based | Urban | Chronic constrictive pericarditis | Pericardiectomy. | 120 | 60 | 28.8 | 8–51 | NR | Chest X-ray, bacteriology and histology. | NA | 15 | 12.5 |
NR, not reported.